Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
89bio, Inc. ETNB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.93
-9.37 %
$ 842 M
Market Cap
-2.68
P/E
Price Target
Average
177.43%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
18.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
89bio, Inc.
Wall Street analysts predict an average 1-year price target for
ETNB
of
$22
, with forecasts ranging from a low of
$12
to a high of
$29
.
ETNB Lowest Price Target
Wall Street Target
12 USD
51.32%
ETNB Average Price Target
Wall Street Target
22 USD
177.43%
ETNB Highest Price Target
Wall Street Target
29 USD
265.70%
REVENUE FORECAST
Revenue Forecast Chart
ETNB
EBIT FORECAST
EBIT Forecast Chart
ETNB
NET INCOME FORECAST
Net Income Chart
ETNB
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan